Literature DB >> 33960261

Incidence and causes of 30-day readmission rate from discharge as an indicator of quality care in pediatric surgery.

Miro Jukić1, Jelena Antišić2, Zenon Pogorelić1,2.   

Abstract

AIM: Evaluation and comparison 30-day readmission rate (ReAd) from discharge within three year period and to note could it be a quality-of-care indicator in pediatric surgery.
METHODS: The case records of the patients that were readmitted within 30 days of primary surgery from January 1st2017 to December 31st2019 were identified retrospectively, for each year separately. Demographic data, diagnosis and the treatment on primary admission, length of hospital stay, and diagnosis with treatment on readmission, were collected. For each year readmissions were identified and divided into two groups (emergency and elective) based on the nature of the primary surgery. Outcomes were compared between two groups.
RESULTS: A total of 5392 admissions were identified among three years (2017, n = 1821; 2018, n = 1806; 2019, n = 1765). There was 1014(55.6%) elective admissions in 2017, 953(52.8%) in 2018 and 950(53.8%) in 2019. The overall ReAd rate was 0.82%, 0.99% and 0.57% for years 2017, 2018 and 2019, respectively (p = 0.348). The most common cause for readmission was appendicitis related followed by surgical site infection in different subfields. The share of the number of readmissions during the three-year period is 3.2 times higher for emergency admissions than for elective admissions (p < 0.001). The majority(>75%) of all readmission in all three years occurred in children above age of eight. Male gender was significantly more frequently associated with readmission(74.4%)(p < 0.001).
CONCLUSION: ReAd is a reproducible and good quality-of-care indicator in pediatric surgery. An incidence of ReAd is significantly higher in emergency admissions and an appendectomy is the most common procedure associated with ReAd.

Entities:  

Keywords:  ReAd; Readmission; children; pediatric surgery; quality of surgical care

Year:  2021        PMID: 33960261     DOI: 10.1080/00015458.2021.1927657

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  6 in total

1.  Clinical Experience of Emergency Appendectomy under the COVID-19 Pandemic in a Single Institution in South Korea.

Authors:  Yun Suk Choi; Jin Wook Yi; Chris Tae Young Chung; Woo Young Shin; Sun Keun Choi; Yoon Seok Heo
Journal:  Medicina (Kaunas)       Date:  2022-06-09       Impact factor: 2.948

2.  Comparison of the Standard vs. Thoracoscopic Extrapleural Modification of the Nuss Procedure-Two Centers' Experiences.

Authors:  Miloš Pajić; Damjan Vidovič; Radoica Jokić; Jelena Antić; Nenad Čubrić; Ivana Fratrić; Svetlana Bukarica; Aleksandar Komarčević; Marina Milenković
Journal:  Children (Basel)       Date:  2022-04-14

3.  Explainable machine learning models for predicting 30-day readmission in pediatric pulmonary hypertension: A multicenter, retrospective study.

Authors:  Minjie Duan; Tingting Shu; Binyi Zhao; Tianyu Xiang; Jinkui Wang; Haodong Huang; Yang Zhang; Peilin Xiao; Bei Zhou; Zulong Xie; Xiaozhu Liu
Journal:  Front Cardiovasc Med       Date:  2022-07-26

4.  Same-Day Discharge after Laparoscopic Appendectomy for Simple Appendicitis in Pediatric Patients-Is It Possible?

Authors:  Miro Jukić; Alexander Tesch; Jakov Todorić; Tomislav Šušnjar; Klaudio Pjer Milunović; Tomislav Barić; Zenon Pogorelić
Journal:  Children (Basel)       Date:  2022-08-12

5.  The Incidence and Causes of Unplanned Reoperations as a Quality Indicator in Pediatric Surgery.

Authors:  Miro Jukić; Ivona Biuk; Zenon Pogorelić
Journal:  Children (Basel)       Date:  2022-01-13

Review 6.  Incidence of Complicated Appendicitis during the COVID-19 Pandemic versus the Pre-Pandemic Period: A Systematic Review and Meta-Analysis of 2782 Pediatric Appendectomies.

Authors:  Zenon Pogorelić; Sachit Anand; Tomislav Žuvela; Apoorv Singh; Zvonimir Križanac; Nellai Krishnan
Journal:  Diagnostics (Basel)       Date:  2022-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.